Kolexia
Pudlarz Thomas
Oncologie médicale
Gustave-Roussy
Villejuif, France
49 Activités
200 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Instabilité des microsatellites Adénocarcinome Tumeurs colorectales Carcinomes Tumeurs de l'estomac Tumeurs colorectales héréditaires sans polypose Tumeurs du pancréas Tumeurs des voies biliaires Récidive tumorale locale

Industries

M3 Global Research Ltd
16 collaboration(s)
Dernière en 2023
A+A
2 collaboration(s)
Dernière en 2020
VIATRIS MEDICAL
1 collaboration(s)
Dernière en 2022
Pfizer
1 collaboration(s)
Dernière en 2020

Dernières activités

Codon-specific KRAS mutations predict survival in advanced pancreatic cancer
ESMO Gastrointestinal Oncology   01 mars 2024
Pancreatic adenocarcinoma third line systemic treatments: a retrospective cohort study.
BMC cancer   26 février 2024
Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care.
British journal of cancer   25 janvier 2024
Precision medicine for KRAS wild-type pancreatic adenocarcinomas.
European journal of cancer (Oxford, England : 1990)   15 décembre 2023
Programme Interception - Parcours Poumons par Dr Thomas Pudlarz
Youtube @ Gustave Roussy   31 octobre 2023
1734P Early impact of a personalized lung cancer interception program for heavy smokers
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
1667P Clinical and molecular features of young onset pancreatic adenocarcinoma
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
112P Clinical, genomic and transcriptomic characteristics of young-onset biliary tract cancers
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
NEONIPIGA: Peri-operative Association of Immunotherapy (Pre-operative Association of Nivolumab and Ipilimumab, Post-operative Nivolumab Alone) in Localized Microsatellite Instability (MSI) and/or Deficient Mismatch Repair (dMMR) Oeso-gastric Adenocarcinoma: An Open-label GERCOR Phase II Study
Essai Clinique (BMS)   27 septembre 2023
Targetable Molecular Alterations in the Treatment of Biliary Tract Cancers: An Overview of the Available Treatments.
Cancers   06 septembre 2023